Labcorp Holdings Inc. (LH)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Labcorp Holdings Inc. (LH)
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Key Insights
Critical company metrics and information
Share Price
$238.34Market Cap
$19.93 BillionTotal Outstanding Shares
83.64 Million SharesTotal Employees
67,000Dividend
$0.72 Per Share QuarterlyIPO Date
April 24, 1991SIC Description
Services-medical LaboratoriesHomepage
https://www.labcorp.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-1.49 Billion |
| Net Cash Flow, Continuing | $780.50 Million |
| Net Cash Flow From Operating Activities | $1.39 Billion |
| Net Cash Flow From Operating Activities, Continuing | $1.39 Billion |
| Net Cash Flow From Financing Activities | $880.10 Million |
| Net Cash Flow | $790.40 Million |
| Net Cash Flow From Financing Activities, Continuing | $880.10 Million |
| Net Cash Flow From Investing Activities, Continuing | $-1.49 Billion |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $1.20 Million |
| Income/Loss From Continuing Operations After Tax | $436.70 Million |
| Basic Average Shares | $167.30 Million |
| Selling, General, and Administrative Expenses | $2.17 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Income Tax Expense/Benefit, Deferred | $-118.50 Million |
| Cost Of Revenue | $9.16 Billion |
| Costs And Expenses | $11.97 Billion |
| Income/Loss From Continuing Operations Before Tax | $12.71 Billion |
| Gross Profit | $3.55 Billion |
| Income Tax Expense/Benefit | $191.90 Million |
| Income/Loss From Equity Method Investments | $600000.00 |
| Diluted Earnings Per Share | $5.27 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Net Income/Loss Attributable To Parent | $435.50 Million |
| Revenues | $12.71 Billion |
| Income/Loss Before Equity Method Investments | $12.71 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $435.50 Million |
| Benefits Costs and Expenses | $0.00 |
| Other Operating Expenses | $634.40 Million |
| Operating Expenses | $2.80 Billion |
| Operating Income/Loss | $747.40 Million |
| Basic Earnings Per Share | $5.31 |
| Interest Expense, Operating | $193.70 Million |
| Income/Loss From Discontinued Operations Net Of Tax | $0.00 |
| Net Income/Loss | $436.70 Million |
| Diluted Average Shares | $168.20 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Current Assets | $3.74 Billion |
| Inventory | $483.10 Million |
| Liabilities And Equity | $18.61 Billion |
| Equity Attributable To Parent | $8.17 Billion |
| Intangible Assets | $3.54 Billion |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Liabilities | $10.43 Billion |
| Other Current Liabilities | $2.75 Billion |
| Equity | $8.17 Billion |
| Fixed Assets | $3.05 Billion |
| Current Assets | $4.91 Billion |
| Noncurrent Assets | $13.70 Billion |
| Prepaid Expenses | $684.70 Million |
| Assets | $18.61 Billion |
| Other Non-current Assets | $7.11 Billion |
| Accounts Payable | $660.90 Million |
| Current Liabilities | $3.41 Billion |
| Noncurrent Liabilities | $7.02 Billion |
Historical Dividends
Current dividend: $0.72 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Oct 10, 2024 | Dec 13, 2024 | Nov 26, 2024 | $0.72 | Quarterly |
| Jul 25, 2024 | Sep 13, 2024 | Aug 29, 2024 | $0.72 | Quarterly |
| Apr 11, 2024 | Jun 12, 2024 | May 28, 2024 | $0.72 | Quarterly |
| Jan 12, 2024 | Mar 13, 2024 | Feb 27, 2024 | $0.72 | Quarterly |
| Oct 12, 2023 | Dec 12, 2023 | Nov 8, 2023 | $0.72 | Quarterly |
| Jul 13, 2023 | Sep 8, 2023 | Aug 8, 2023 | $0.72 | Quarterly |
| Apr 6, 2023 | Jun 8, 2023 | May 18, 2023 | $0.72 | Quarterly |
| Jan 12, 2023 | Mar 13, 2023 | Feb 23, 2023 | $0.72 | Quarterly |
| Oct 12, 2022 | Dec 9, 2022 | Nov 17, 2022 | $0.72 | Quarterly |
| Jul 14, 2022 | Sep 9, 2022 | Aug 18, 2022 | $0.72 | Quarterly |
| Apr 7, 2022 | Jun 9, 2022 | May 19, 2022 | $0.72 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Labcorp Holdings Inc. (LH)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.